Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
100

Summary

Conditions
COVID
Type
Interventional
Phase
Phase 2Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Participant)Primary Purpose: Treatment

Participation Requirements

Age
Younger than 125 years
Gender
Both males and females

Description

COVID 19 treatment using Remedesvir. Is this drug effective?

COVID 19 treatment using Remedesvir. Is this drug effective?

Tracking Information

NCT #
NCT04345419
Collaborators
Not Provided
Investigators
Principal Investigator: Sherief Abd-Elsalam, ass. prof. Tanta University Faculty of medicine